OTC Healthcare in Egypt
Euromonitor International's OTC Healthcare in Egypt market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 99 | Publication date: Jun 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Dynamic growth in OTC healthcare in Egypt
In 2008, OTC healthcare showed dynamic growth of 7%, despite the rigid control of the Ministry of Health over this market. The total market remained small in comparison with the population in Egypt, which reached 75 million in 2008. Low labour costs and the high annual increase in the population continued to encourage companies to manufacture new products in the country. However, on the other hand the lack of transparency and strong competition between the existing companies did not encourage new entrants.
The rigid control of the Ministry of Health is a constraint to sales
The Ministry of Health controls prices, sales and distribution of OTC and Rx products in Egypt. The laws are unclear, and the bureaucracy for new entrants and new product developments is complicated. The government insists on keeping the prices of drugs in Egypt low, despite the high inflation rate and the devaluation of the Egyptian pound against the dollar, in order to ensure that medication is affordable even to poorer segments of Egyptian society. So, although the prices of all commodities are increasing at a high rate as a result of very high inflation, prices of OTC healthcare products remain stable because inflation does not affect the prices of these products in the Egyptian market. There are no advertisements allowed for any OTC product except medicated confectionery; this type of product is not considered as an OTC product in Egypt.
Egyptian companies and multinationals compete for market share
In terms of market share, GlaxoSmithKline Egypt continued to lead with a 12% value share in 2008. Most multinationals are present in the Egyptian market, and compete with local companies. Vitamins and dietary supplements continued to lead value sales of OTC healthcare in Egypt in 2008, representing nearly a 25% share of overall sales in OTC healthcare. Egyptian companies try to develop cheap vitamins in order meet demand and compete with multinationals.
Distribution is only allowed through chemists/pharmacies
The distribution of most OTC products in Egypt is only allowed in chemists/pharmacies, due to strict regulations set by the Ministry of Health. There are about 30,000 pharmacies in Egypt, scattered all around Egypt. At the beginning of 2009, all pharmacies closed their doors for two consecutive days after the Ministry of Health announced that pharmacies would have to return to the pre-2005 tax laws and lose the tax exemption which was given in 2005. Returning to the old law means that pharmacies will have to pay taxes not only on medicines, but also on everything else sold in pharmacies, such as make-up, creams, shampoos, boxed facial tissues and many more. Due to the unit prices of medicines being very low in Egypt, and most products being subsidised by the government, pharmacies get more revenue from selling cosmetics and toiletries and household care products.
A bright forecast for OTC healthcare
Growth in the OTC healthcare market in Egypt is expected to be dynamic, reaching a constant value CAGR of 6%. Unit prices are expected to remain constant due to the rigid control of the Ministry of Health over retail prices. Most drugs will continue to be subsidised by the government in order to be affordable by the majority of the population. Only a few products are expected to enter the market during the forecast period, due to complicated procedures and registration set by the Ministry of Health. The environment for OTC production will continue to discourage new entrants to the market.
Table of contents
OTC HEALTHCARE IN EGYPT : MARKET INSIGHT
EXECUTIVE SUMMARY
Dynamic growth in OTC healthcare in Egypt
The rigid control of the Ministry of Health is a constraint to sales
Egyptian companies and multinationals compete for market share
Distribution is only allowed through chemists/pharmacies
A bright forecast for OTC healthcare
KEY TRENDS AND DEVELOPMENTS
Rigid control by the Ministry of Health over the OTC healthcare market
Low purchasing power hinders sales of OTC healthcare products
Strike of chemists/pharmacies at the beginning of 2009
Lack of awareness of brands in the market
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
DEFINITIONS
Summary 1 Research Sources
LOCAL COMPANY PROFILES - EGYPT
AMOUN PHARMACEUTICAL INDUSTRY CO - OTC HEALTHCARE - EGYPT
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Amoun Pharmaceutical Industry Co: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Amoun Pharmaceutical Industry Co: Competitive Position 2008
ATOS PHARMA - OTC HEALTHCARE - EGYPT
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Atos Pharma: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 5 Atos Pharma: Competitive Position 2008
EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO SAE (EIPICO) - OTC HEALTHCARE - EGYPT
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Egyptian International Pharmaceutical Industries Co SAE (EIPICO): Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 7 Egyptian International Pharmaceutical Industries Co SAE (EIPICO): Competitive Position 2008
KAHIRA PHARMACEUTICAL & CHEMICAL INDUSTRIES CO - OTC HEALTHCARE - EGYPT
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Kahira Pharmaceutical & Chemical Industries Co: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Kahira Pharmaceutical & Chemical Co: Competitive Position 2008
PHARCO PHARMACEUTICALS - OTC HEALTHCARE - EGYPT
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Pharco Pharmaceuticals: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 11 Pharco Pharmaceuticals: Competitive Position 2008
ANALGESICS IN EGYPT
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 15 Analgesics Company Shares by Value 2004-2008
Table 16 Analgesics Brand Shares by Value 2005-2008
Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN EGYPT
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 21 Sales of Decongestants by Type: Value 2003-2008
Table 22 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN EGYPT
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 30 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 32 Herbal vs Standard Digestive Remedies 2003-2008
Table 33 Digestive Remedies Company Shares by Value 2004-2008
Table 34 Digestive Remedies Brand Shares by Value 2005-2008
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN EGYPT
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 37 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 39 Herbal vs Standard Medicated Skin Care 2003-2008
Table 40 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 41 Medicated Skin Care Company Shares by Value 2004-2008
Table 42 Medicated Skin Care Brand Shares by Value 2005-2008
Table 43 Acne Treatments Brand Shares by Value 2005-2008
Table 44 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN EGYPT
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Summary 12 Dietary Supplements: Brand Ranking by Positioning 2008
SECTOR DATA
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 49 Folic Acid v Other B Vitamins 2004-2008
Table 50 Dietary Supplements by Positioning 2006-2008
Table 51 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 52 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 53 Vitamins Brand Shares by Value 2005-2008
Table 54 Dietary Supplements Brand Shares by Value 2005-2008
Table 55 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN EGYPT
HEADLINES
EYE CARE IN EGYPT
SECTOR DATA
Table 57 Sales of Eye Care by Subsector: Value 2003-2008
Table 58 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 59 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 60 Eye Care Company Shares by Value 2004-2008
Table 61 Eye Care Brand Shares by Value 2005-2008
Table 62 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 63 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN EGYPT
SECTOR DATA
Table 64 Sales of Ear Care: Value 2003-2008
Table 65 Sales of Ear Care: % Value Growth 2003-2008
Table 66 Ear Care Company Shares by Value 2004-2008
Table 67 Ear Care Brand Shares by Value 2005-2008
Table 68 Forecast Sales of Ear Care: Value 2008-2013
Table 69 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN EGYPT
SECTOR DATA
Table 70 Sales of Adult Mouth Care: Value 2003-2008
Table 71 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 72 Adult Mouth Care Company Shares by Value 2004-2008
Table 73 Adult Mouth Care Brand Shares by Value 2005-2008
Table 74 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 75 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN EGYPT
SECTOR DATA
Table 76 Sales of Calming and Sleeping Products: Value 2003-2008
Table 77 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 78 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 79 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 80 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 81 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN EGYPT
SECTOR DATA
Table 82 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 83 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 84 Wound Treatments Company Shares by Value 2004-2008
Table 85 Wound Treatments Brand Shares by Value 2005-2008
Table 86 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 87 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
OTC OBESITY IN EGYPT
EMERGENCY CONTRACEPTION IN EGYPT
OTC TRIPTANS IN EGYPT